Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
Aim. To study clinical effectiveness of ivabradine (7,5 mg twice a day) as a part of combined therapy, and its effects on physical stress (PS) tolerability in patients with Functional Class (FC) II-III stable angina and absolute or relative contraindications to beta-adrenoblockers (BAB).Material and...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2009-10-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1849 |